John D. Porter, PhD's Friends

View All

John D. Porter, PhD

Profile Information

About me:: Chief Executive Officer

After conducting research in my own laboratory in academia for over 20 years, and then facilitating the funding of neuromuscular disease research by National Institute of Neurological Disorders and Stroke (NINDS) for the next 10 years, PPMD offered me this unparalleled opportunity to synthesize that experience and bring it directly to bear on the challenges of better quality of life and novel treatments for people with Duchenne. I’m thrilled to join such a strong and vibrant team at PPMD, and work with the broader community of dedicated scientists, physicians, patient advocates, and families, in a leave no-stone-unturned approach to end Duchenne.

City:: Washington, DC

John D. Porter, PhD's Blog

A New Dog Model for Drug Development in Duchenne

Posted on December 21, 2015 at 11:03am 0 Comments 0 Favorites

Photograph: Chris Kench/www.chriskenchphotography.com via The Guardian

Some…

Continue

Dystrophin Mutations Affect Not Only Existing Muscle Fibers, but Satellite Cells As Well

Posted on December 17, 2015 at 4:00pm 0 Comments 0 Favorites

A recent paper by Michael Rudnicki’s group at Ottawa Hospital Research Institute and the University of Ottawa has provided new insights into what we view as the critical targets for therapies in Duchenne (Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division.…

Continue

A Paradigm Shift in Drug Discovery

Posted on October 27, 2015 at 10:50am 4 Comments 0 Favorites

Last week I participated in a briefing for Congressional staff in honor of the 10^th anniversary of the founding of the Critical Path Institute, our partner in the…

Continue

Annual Meeting: Patient-Centered Outcomes Research Institute (PCORI)

Posted on October 16, 2015 at 1:07pm 0 Comments 0 Favorites

The first annual meeting of PCORI was held in Washington, DC on October 6-8. 1,100 researchers, patients, caregivers, health system and industry representatives, and others were present to hear updates on patient-centered comparative clinical effectiveness research. PCORnet is a “network of…

Continue